The New England Journal of Medicine (NEJM) published results from part 1 of the ongoing phase 3 ESSENCE trial which investigated the effects of once-weekly subcutaneous semaglutide 2.4 mg on liver ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

University of Kentucky Markey Cancer Center researchers have identified a mechanism by which a gut hormone contributes to ...

White patients had an increased burden of advanced liver fibrosis vs Black patients, despite comparable levels of inflammation.

Doctors can accurately predict a person's risk of fatty liver disease as early as 16 years before symptoms develop, a new ...

Key TakeawaysA blood test can predict fatty liver disease as far as 16 years prior to symptomsThe test looks for five specific blood-borne proteinsThe test was 76% to 84% accurate in predicting liver ...